Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

32
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
32
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

542
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
542
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

872
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
872
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

3.1K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.1K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.5K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Diphtheria01:28

Diphtheria

55
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
55

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accompaniment in the healthcare sector: a systematic review and concept analysis.

Frontiers in medicine·2026
Same author

The Missing Global South in Climate Change Biology: Towards Equitable Knowledge Inclusion for Effective Global Solutions.

Global change biology·2026
Same author

Two new species of Trichodrilus (Annelida, Clitellata, Lumbriculidae) from Pacific drainages, western USA.

Zootaxa·2025
Same author

Erratum: STEVEN FEND & PILAR RODRIGUEZ (2024) Two new species of Trichodrilus (Annelida, Clitellata, Lumbriculidae) from Pacific drainages, western USA. Zootaxa, 5551 (1): 141-156.

Zootaxa·2025
Same author

Typification and Characterization of Different Livestock Production Systems of Mediterranean Dairy Sheep Farms with Different Degrees of Intensification: A Comparative Study.

Animals : an open access journal from MDPI·2025
Same author

Use of screens, books and adults' interactions on toddler's language and motor skills: A cross-cultural study among 19 Latin American countries from different SES.

PloS one·2025

Related Experiment Video

Updated: Mar 29, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K

[Clostridium difficile associated diarrhea in children].

Pilar Rodríguez, José Cofré

    Revista Chilena De Infectologia : Organo Oficial De La Sociedad Chilena De Infectologia
    |December 4, 2015
    PubMed
    Summary

    Clostridium difficile infections (CDI) are a growing concern in healthcare settings and the community. Early diagnosis and appropriate management are crucial for improving outcomes in pediatric patients.

    More Related Videos

    Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
    11:13

    Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

    Published on: September 14, 2013

    40.4K
    Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
    06:51

    Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

    Published on: December 10, 2016

    13.4K

    Related Experiment Videos

    Last Updated: Mar 29, 2026

    Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
    07:06

    Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

    Published on: December 8, 2014

    27.8K
    Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
    11:13

    Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

    Published on: September 14, 2013

    40.4K
    Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
    06:51

    Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

    Published on: December 10, 2016

    13.4K

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Pediatrics

    Background:

    • Clostridium difficile is a leading cause of antimicrobial-associated diarrhea and is increasingly relevant in community-acquired infections.
    • It is a Gram-positive bacillus transmitted via the fecal-oral route, posing risks in both community and hospital settings.
    • While asymptomatic colonization is common, risk factors in children include antibiotic exposure, hospitalization, and immunosuppression.

    Purpose of the Study:

    • To review the epidemiology, diagnosis, management, and prevention of Clostridium difficile infections in pediatric patients.
    • To highlight the increasing incidence, morbidity, and mortality associated with C. difficile.

    Main Methods:

    • Diagnosis relies on clinical criteria and laboratory confirmation with high sensitivity and specificity.
    • Pediatric diagnostic recommendations vary by age, with specific guidelines from the American Academy of Pediatrics (AAP).

    Main Results:

    • Clostridium difficile infection (CDI) can range from asymptomatic colonization to severe, fulminant disease.
    • Management strategies include antimicrobial suspension for mild to moderate cases and vancomycin or metronidazole for severe cases, typically over 10 days.

    Conclusions:

    • Antimicrobial stewardship programs and stringent environmental controls are key preventive measures.
    • Further research is needed to understand and combat the rising complexity and impact of C. difficile in pediatric populations.